| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.07 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.054 | 0.08 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.095 | 0.08 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.08 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.09 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.09 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.06 | 0.09 |